Osteosarcoma Symptoms: Bone Pain and Swelling to Check

Osteosarcoma Symptoms: Bone Pain and Swelling to Check

A sudden broken bone with severe pain, or a limb that looks bent or out of shape, means call 911 or go to the emergency department.

What follows works through the everyday reasons a bone can hurt and swell, the two chemistry markers a clinician can check alongside the symptom, what those results can and cannot tell you, and where they are measured.

What can cause bone pain and swelling?

Everyday mechanical and life-stage causes are the first things a clinician thinks through, including training load, a fall or a knock, overuse around a joint, growth during adolescence, and the effects of some medicines (ask your prescriber).

Bone is living tissue that adapts to load. A jump in running volume, a new sport, a change of surface or a return to training after a layoff can all produce aching in the shin, foot, hip or thigh that comes on with weight bearing and eases with rest. The same loading pattern can produce swelling and warmth over a joint rather than over the bone itself, which points a clinician towards tendon, bursa or joint structures.

Direct injury is its own category. A knock over a bone with little soft tissue covering it, such as the shin or the elbow, can swell and stay tender for a long stretch. A sprain or a strain near a joint can look like bone pain to the person feeling it, because the ache sits deep and does not move with the skin.

Life stage matters. If the pain belongs to a child or a teenager, ask your child's pediatrician rather than working from a symptom list at home. At the other end of life, bone changes with age, and new bone pain in an older adult is worth bringing to a clinician rather than watching.

Sleep, stress, alcohol and diet sit in the background of any pain complaint. Short sleep and sustained stress can change how pain is perceived and how well tissue recovers between training sessions. Low overall energy intake relative to training, along with low intake of calcium and vitamin D, can affect how bone handles load. None of these show up as a tumour on a blood panel, and none of them are read from a single number.

Research suggests that osteosarcoma is the most common primary cancer of bone, while remaining uncommon in the population as a whole 2. Research suggests that it has two peaks in age, one in adolescence and young adulthood and a second in older adults 1. Research suggests that taller stature and rapid skeletal growth are associated with osteosarcoma risk 1. Research suggests that the long bones around the knee and the upper arm account for more cases than other sites 2.

The picture is not limited to those sites. Studies indicate that osteosarcoma can also arise in soft tissue rather than in bone, where it is called extra-skeletal osteosarcoma 4. A case series and review describe primary osteosarcoma in people over 75 years of age, so age alone does not take it off a clinician's list 5. A further case analysis describes osteosarcoma of the skull base, where the complaint can present through head and neck symptoms instead of a painful limb 6.

Which blood tests can help explain it?

No blood test can identify a bone tumour, and no result takes one off the table. Two chemistry markers add context to a bone complaint, alkaline phosphatase and calcium, and guidance from the National Comprehensive Cancer Network for bone cancer includes blood chemistry as part of the initial workup when a bone tumour is suspected 3.

Marker Why a clinician may check it What a result can and cannot tell you
Alkaline phosphatase An enzyme produced by bone-building cells and by the liver and bile ducts, so it moves with bone-forming activity as well as with liver activity. Guidance from the National Comprehensive Cancer Network includes blood chemistry in the workup of a suspected bone tumour 3. Can show that bone-forming or liver activity is higher than the range printed on your lab report. Cannot say where in the body that activity sits, and cannot identify a tumour. A clinician decides what the value reflects.
Calcium Bone is the body's calcium reservoir, and circulating calcium is held in a narrow band by hormones, the kidneys and the gut. A value outside the printed range changes what a clinician asks next. Can show how much calcium is circulating at the moment of the draw. Cannot measure bone strength, cannot locate a bone lesion, and is affected by hydration, albumin and the draw itself.

Ranges vary by lab, by age and by sex, so read your own result against the range as printed on your lab report. A value outside that printed range is worth discussing with a clinician, who decides what it reflects.

Can a high alkaline phosphatase result explain bone pain?

A raised alkaline phosphatase result does not explain pain on its own. It says more enzyme activity is reaching the bloodstream from bone, from the liver and bile ducts, or from both, and it takes a clinician to work out which.

The mechanism is straightforward. Bone-building cells release alkaline phosphatase while they lay down new bone matrix, so anywhere bone is being built or remodelled at speed, the enzyme rises in the blood. That is why a growing adolescent can sit above an adult range without anything unusual happening, and why the number can move while a fracture heals. Liver cells and the cells lining the bile ducts release their own form of the same enzyme, which is why a clinician reads alkaline phosphatase alongside the rest of a chemistry panel rather than alone.

Guidance from the National Comprehensive Cancer Network for bone cancer places blood chemistry, alongside imaging and biopsy, in the assessment of a suspicious bone lesion 3. That is the honest framing for this marker in the context of bone pain. It is a piece of background information that sits next to the examination and the imaging, not a test that answers the question by itself.

Plenty of other things move the number. Growth, fracture healing, pregnancy, liver and bile duct conditions, thyroid and parathyroid activity, and some medicines (ask your prescriber) all shift alkaline phosphatase. Day to day lab variation adds a little more noise. A result that sits a little outside the printed range on a single draw is a reason for a conversation, not a conclusion.

The practical sequence is the same every time. The observation is a number outside the range printed on your report. The possible meaning spans bone activity, liver activity and ordinary variation. The next step is to bring the result, and the symptom that prompted it, to a clinician who can examine the painful area and decide what else is needed. You can read more about what the enzyme measures on the Alkaline Phosphatase marker page.

Can a calcium test say anything about bone pain?

A calcium result tells you how much calcium is circulating at the moment the blood was drawn, not how strong your bones are, and it cannot locate or identify a bone lesion.

Circulating calcium is held in a tight band by parathyroid hormone, vitamin D, the kidneys, the gut and the skeleton itself. Bone acts as the reservoir, releasing or storing calcium to keep blood levels steady. Because the system defends that band so firmly, a calcium value outside the range printed on your report is a signal that something in the regulating system deserves attention, and it is worth discussing with a clinician promptly.

Much of what moves calcium has nothing to do with bone pain. Hydration status changes the concentration. Albumin carries about half of the circulating calcium, so a low albumin can pull total calcium down while the active fraction is unchanged, which is why an ionized calcium or an albumin-corrected value is sometimes requested. A long tourniquet time or a clenched fist during the draw can nudge the number. Parathyroid activity, vitamin D status, kidney function and some medicines (ask your prescriber) all sit in the picture. Some illnesses that change bone turnover also change calcium, and sorting between those possibilities is clinical work, not something to do from a results portal.

Guidance from the National Comprehensive Cancer Network for bone cancer frames blood chemistry as supporting information in the assessment of a bone lesion rather than as the test that settles the question 3. Read a calcium result the same way. Note the value, note whether it sits outside the printed range, and bring it to a clinician along with how the pain behaves. The Calcium marker page covers what the test measures in more detail.

What can a normal panel still miss?

A chemistry panel sitting entirely inside the printed ranges does not take a bone tumour off the table, because blood chemistry is not how a bone lesion is found. Guidance from the National Comprehensive Cancer Network for bone cancer describes imaging of the painful area and a biopsy as the steps that characterise a suspicious bone lesion 3.

The gaps run in several directions. A lesion can sit in a bone while the enzymes and minerals in the blood stay inside range, which is why a persistent, well-localised bone pain is assessed on its own merits regardless of how the labs read. Studies indicate that osteosarcoma can arise in soft tissue outside the skeleton, where the complaint can be a deep mass rather than bone pain 4. A case analysis describes skull base osteosarcoma presenting through head and neck symptoms, a site no limb-focused assessment would reach 6.

The everyday causes are just as invisible to a chemistry panel. A bone stress reaction, a tendon problem, a ligament injury, a nerve irritation referring pain down a limb, a joint surface changing with age, none of these produce a signature on alkaline phosphatase or calcium. The same is true in reverse. A result outside the printed range can appear in a person whose bone pain has an entirely separate and unrelated explanation.

This is why the symptom drives the assessment and the labs follow it. Blood markers narrow the questions a clinician asks and flag systems worth a closer look. The description of the pain, how long it has lasted, whether it wakes you, whether there is a swelling you can feel, and what the examination finds are what decide whether imaging happens.

When should you see a clinician quickly?

Any new bone pain that lasts beyond a few weeks, wakes you at night, or sits under a firm swelling needs a clinician's assessment, and a short list of signs needs emergency care right now.

Call 911 or go to the emergency department for any of these.

See a clinician promptly, within days, for any of these.

Do not try to work the cause out yourself from a symptom list. A clinician examines the area, asks how the pain behaves across a day and a night, and decides whether imaging or any further test is needed. Bring the timeline, the exact spot, and any lab results you already have.

If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.

How can you check these markers?

Alkaline phosphatase and calcium both sit in a standard blood chemistry panel, so they are measured from a single draw. The FitScript Essential panel includes both markers alongside the rest of a baseline chemistry, which gives a clinician the liver, kidney and mineral context needed to read either number sensibly rather than in isolation.

Results land as numbers next to the range printed by the lab that ran them. Atlas, FitScript's AI health advisor, explains what each marker measures and what moves it, in plain language, so you arrive at an appointment knowing what you are looking at. Interpretation of a result in the context of your symptoms, and any decision about imaging or further testing, belongs to a licensed clinician, and treatment decisions belong to a licensed provider.

Retesting has its own logic. A single value outside a printed range can reflect the draw, recent training, hydration or ordinary variation. Bring both results, and the symptom that started the question, to the person doing the assessing.

This page is educational and is not medical advice. Discuss your results, your symptoms and any treatment with a clinician or licensed provider.

Key takeaways

References

  1. Epidemiology and Risk Factors of Osteosarcoma. Cancer Investigation, 2020.
  2. The epidemiology of osteosarcoma. Cancer Treatment and Research, 2009.
  3. Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 2025.
  4. Extra-skeletal osteosarcoma: a review. Skeletal Radiology, 2023.
  5. Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review. In Vivo, 2022.
  6. Skull Base Osteosarcoma: An Analysis of 9 Cases and Literature Review. Head and Neck Pathology, 2025.

Common questions

What are osteosarcoma signs and symptoms?

Bone pain that persists for weeks or wakes you at night, swelling or a firm lump over a bone, a joint that loses movement, a new limp, and a bone that breaks after minor force are the signs clinicians ask about. These can come from everyday causes too, so a clinician examines you and decides whether imaging is needed.

Where in the body does this kind of bone pain show up?

The long bones around the knee and the upper arm are the sites described in the medical literature, so pain and swelling just above or below the knee gets particular attention. Other bones can be involved, and the same type of tumour is described in soft tissue and at the skull base. Location alone does not answer the question, which is why imaging is the next step a clinician considers.

Can a blood test identify osteosarcoma?

No. No blood marker identifies a bone tumour and no normal result takes one off the table. Imaging of the painful area and, where needed, a biopsy are what a clinician uses, with blood chemistry such as alkaline phosphatase and calcium providing background context.

What can a high alkaline phosphatase result reflect?

It reflects more of the enzyme reaching the bloodstream, from bone-building activity, from the liver and bile ducts, or from both. Adolescent growth and a healing fracture both raise it, as can liver and bile duct conditions, pregnancy and some medicines, so ask your prescriber about anything you take. A value outside the range printed on your lab report is worth discussing with a clinician, who decides what it reflects.

Does a normal calcium result mean my bones are fine?

No. Calcium in blood is held in a narrow band by hormones, the kidneys and the skeleton, so the value can sit inside the printed range while something in the bone needs attention. The test measures what is circulating at the moment of the draw, not bone strength. Bone density is measured by a different type of test that a clinician orders when it is appropriate.

How is training-related bone pain different from pain that needs assessment?

Pain tied to load generally builds with activity and eases when you stop, and it tracks with a recent jump in training volume or a change in surface or footwear. Pain that is present at rest, wakes you at night, or sits under a swelling you can feel behaves differently. Either way, bone pain that lasts more than a few weeks is worth a clinician's assessment.

Who can develop osteosarcoma?

It is described in adolescents and young adults, where rapid skeletal growth is part of the picture, and again in older adults, including people over 75. Adults of any age can present with new bone pain that deserves assessment. If the person with the symptom is a child or a teenager, ask your child's pediatrician.

What happens after an alkaline phosphatase or calcium result comes back outside the range?

A clinician reads the value against your history, your symptoms and the rest of the panel, and will often repeat the test under steadier conditions before drawing any conclusion. From there they decide whether imaging or further testing is needed. The decision about any next step belongs to the clinician, not to the result on its own.

Related reading